MyDosageBeta
Canonical · evidence-anchored

Cagrilintide — appetite control

Amylin analog; weekly subq titration focused on satiety.

16 weeks3 variantsclinical2 evidence nodes
Outcomes this template targets
  • Appetite & food-noise suppression
    Weight 100%
  • Weight / fat reduction
    Weight 70%
Pick a variant

Same template. Three intensities.

Gentle, Balanced, Advanced. We adjust dose curve, ramp, monitoring and check-in cadence — the science pattern stays identical.

Stack at balanced

Doses adjust with the variant.

  1. 01
    cagrilintide
    Titrate every 4 weeks per tolerance.
    0.3 mg → 2.4 mg
    1x weekly
Monitor
  • — nausea
  • — weight
  • — HR
  • — fasting glucose
Stop rules
  • — intolerable GI
  • — HR drop
Ready to run this?

Start a journey at the Balanced variant.

Begin onboarding